News

DexCom Stock Rises as Glucose Monitoring System Gets FDA Clearance
DexCom stock was on the rise Thursday after the maker of medical technology said it had received clearance from the U.S. Food ...
CNET on MSN6h
The FDA Just Cleared the Dexcom G7 15-Day, the Longest-Lasting CGM
The US Food and Drug Administration has cleared the Dexcom G7 15-Day Continuous Glucose Monitor (CGM) for people older than ...
MPR7h
FDA Clears Dexcom G7 15 Day for Continuous Glucose Monitoring
The Dexcom G7 15 Day CGM system is a wearable sensor that continuously measures glucose levels and transmits readings every 5 minutes with no fingersticks or scanning required.
Fierce Biotech13h
Dexcom wins FDA clearance for 15-day G7 CGM sensor
Dexcom has won a clearance from the FDA for its longest-lasting continuous glucose monitor, a 15-day version of its flagship ...
Dexcom G7 15 Day Receives FDA Clearance: the Longest Lasting Wearable and Most Accurate CGM System
DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, announced today the FDA has cleared the Dexcom G7 15 Day ...
FDA Approves New DexCom Diabetes Device
The Food and Drug Administration has cleared diabetes-management firm DexCom's new continuous glucose monitoring (CGM) system ...
FDA Approves Dexcom's 15-Day Wearable Glucose Management System. Company Plans US Launch
The U.S. Food and Drug Administration approved DexCom, Inc.’s (NASDAQ:DXCM) Dexcom G7 15-Day Continuous Glucose Monitoring System for people over 18 with diabetes. With an overall Mean Absolute ...
Medscape10h
FDA Clears Dexcom G7 CGM for 15-Day Wear
The US Food and Drug Administration has cleared the latest version to last 5 days longer than previously for adult users.
Drug Delivery Business15h
Dexcom wins FDA nod for 15-day CGM
Dexcom (Nadsaq:DXCM) announced today that the FDA cleared its G7 15-day continuous glucose monitoring (CGM) system.
DexCom Shares Rise in Premarket on FDA Clearance for Glucose Monitoring System
Shares traded 8.5% higher at $72.55. The company, which focuses on glucose biosensing--which measures glucose levels in wearers--said that the Food and Drug Administration has cleared the Dexcom G7 15 ...
DexCom receives FDA Clearance for Dexcom G7 15 Day
DexCom (DXCM) announced the FDA has cleared the Dexcom G7 15 Day continuous glucose monitoring system for people over the age of 18 with ...
Investing.com Australia15h
DexCom shares rise on FDA clearance for new CGM system
The San Diego-based medical device company stated that the Dexcom G7 15 Day has an overall Mean Absolute Relative Difference (MARD) of 8.0%, showcasing its precision in glucose level readings. The ...